http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111282165-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dfd177ee49bc20c2cfde8d2cd4fe251d |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N2005-1051 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N5-1049 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N5-10 |
| filingDate | 2020-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31092db64614663f9704c7fc81e7f570 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_860dc190bbb728745ccb265ddd42901c |
| publicationDate | 2020-06-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111282165-A |
| titleOfInvention | Radiotherapy positioning developing solution and positioning developing mark application |
| abstract | The invention relates to a radiotherapy positioning developing solution and a developing mark application, wherein the radiotherapy positioning developing solution comprises the following raw material components in parts by weight: 5-10 parts of genipin, 0.2-0.8 part of xanthan gum, 1-10 parts of carmine powder, 80-100 parts of absolute ethyl alcohol, 1-8 parts of sorbitol, 0.0001-0.4 part of acetic acid and 80-100 parts of water. The positioning developing mark application comprises a hard cross plotting stripping layer, a PU film layer, a silica gel framework layer, an adhesive layer, a developing solution adsorption layer and a lower stripping layer. The radiotherapy positioning developing solution provided by the invention not only shortens the reaction time, but also greatly improves the coloring effect, and the skin mark can be kept for 15-20 days. The positioning developing mark application structure is ingenious, the application forming effect is more durable, the cross mark line is straighter and cannot be bent, normal operation can be performed even if the body surface is uneven, and normal movement of a patient cannot be influenced. |
| priorityDate | 2020-03-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 31.